Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study (Q43690970)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2001
edit
Language Label Description Also known as
English
Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study
scientific article published in August 2001

    Statements

    Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study (English)
    P G Noone
    N Hamblett
    F Accurso
    M L Aitken
    R Gibson
    C Johnson
    D Kellerman
    M W Konstan
    L Milgram
    J Mundahl
    G Retsch-Bogort
    D Rodman
    J Williams-Warren
    R W Wilmott
    P Zeitlin
    B Ramsey
    Cystic Fibrosis Therapeutics Development Research Group
    1 August 2001
    122-128

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit